Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SafeBreach executes active breach scenarios and performs continuous validation to find holes in an environment before an attacker does.
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Teckro is a life science technology company that is rethinking every element of clinical research.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Powering precision proteomics to enable to the earliest detection of disease.
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.
Tellius is an AI-powered business analytics platform designed to help enterprises accelerate data-driven insight and decision-making.
JumpCloud is an open directory platform for secure, frictionless access from any device to any resource, anywhere.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Codoxo leverages advanced generative and self-learning AI to enhance payment integrity in healthcare.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
RevEng.ai is a deep AI framework for analysing binary computer programs.
Chronicle Studios operates as an entertainment company.
Spyglass Pharma provides medicine for ophthalmic diseases.
Specialty-specific healthcare SaaS solutions including AI-Powered EHRs, Practice Management, Analytics, RCM, Patient Engagement, Payments
AI based, real-time Anti Money Laundering (AML) detection, Fraud Prevention, Sanction Screening.
SafeRide Health is a healthcare technology platform developer that aims to simplify medical services.
pgEdge offers distributed PostgreSQL to deliver high availability and reduced data latency for mission-critical applications.
CompScience provides AI-driven insights for workers' compensation insurance and safety.
Sands Capital Ventures has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sands Capital Ventures's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Software. The firm invests across 53 different industry categories.
Among tracked funding rounds, Dice Therapeutics received $345.0M in a Post-IPO Equity round. Sands Capital Ventures's total known invested capital is $4.1B.
Sands Capital Ventures's average investment size is $49.9M across its portfolio of 99 companies.
Recent Sands Capital Ventures portfolio additions include SafeBreach, Elephas, Teckro, Thrive Earlier Detection, Beta Bionics. These companies were founded in 2020 or later.